Logo
Europe Enteral Nutrition Market 2020 2030

Europe Enteral Nutrition Market 2020 2030

Bonafide Trust 26-10-2020 119 Pages Figures : 56 Tables : 37
Region : Europe Category : Lifescience Pharmaceutical

Europe enteral nutrition market accounted for $2,107.6 million in 2019 and will grow by 8.1% annually over 2020-2030 owing to rising number of patients suffering with chronic diseases and surge in adoption of enteral nutrition amid COVID-19 pandemic. Highlighted with 37 tables and 56 figures, this 119-page report “Europe Enteral Nutrition Market 2020-2030 by Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe enteral nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe enteral nutrition market in every aspect of the classification from perspectives of Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country. Based on Nutrient, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Protein Based Nutrition • Standard Protein Diet • High Protein Supplement • Protein for Diabetic Patients • Other Protein-based Nutitions Carbohydrates Based Nutrition Fat Based Nutrition Vitamin Based Nutrition Other Nutrition Types Based on Application, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Critical Care • Diabetes • Neurology • Oncology • Other Applications Based on Category, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Enteral Nutrition for Chronic Illness • Enteral Nutrition with Standard Formula Based on Product Form, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Liquid Enteral Nutrition • Powder Enteral Nutrition Based on End User, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Pediatric • Adults • Geriatric Based on Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Distribution by Hospitals • Distribution by Retail Pharmacies • Distribution by Online Pharmacies Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Russia • Rest of Europe (further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Nutrient, Application, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in Europe enteral nutrition market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Abbott Laboratories B. Braun Melsungen AG Baxter International, Inc. Danone S.A. Fresenius Kabi AG Europe Health Products, Inc. Hormel Foods Corporation Mead Johnson Nutrition Company Meiji Holdings Co., Ltd. Nestle S.A. Reckitt Benckiser Group LLC Victus, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Read More

Card image cap

Interested in this report?
Get your FREE sample!

Requirement Gathering & Methodology
Data Collection Techniques
Our Research Team & Data Sourcing
Data Science & Analytical Tools
Data Visualization & Presentation Skills
Project/ Report Delivery & After Sales Services